PM360

OCTOBER 28, 2022

in 2010 to only 1.9% Promising AI Use Cases in Pharma. Although we’re still at the beginning of the AI revolution in pharma, promising use-cases have already been identified: Drug discovery: In drug discovery , AI models are predicting the 3D structure of target proteins at an unprecedented scale.

Pharma 105

Pharma Food and Drug Administration Medicine Government 105

Pharmaceutical Technology

MARCH 14, 2023

The company’s lead asset is NBTXR3, which is based on hafnium oxide nanoparticle that is designed to destroy tumors when activated by radiotherapy. ‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 72

Leads Biopharma Pharmaceutical Manufacturing 72

Pharmaceutical Technology

MAY 15, 2023

Patent volumes related to nucleoside chemical synthesis Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Gilead Sciences 544 Unlock company profile Johnson & Johnson 420 Unlock company profile Merck & Co 303 Unlock company profile Illumina 238 Unlock company profile F.

Pharmaceutical 64

Pharmaceutical Leads Pharma Medicine 64

Pharmaceutical Technology

MARCH 14, 2023

Patent volumes related to platinum-based cancer drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Bristol-Myers Squibb 281 Unlock company profile F. In terms of application diversity, Synlogic is the top company, followed by Traslational Cancer Drugs Pharma and Calgent Biotechnology.

Leads 52

Leads Pharmaceutical Pharma 52

European Pharmaceutical Review

FEBRUARY 1, 2024

Dr Michael Davidson is CEO of biotech company NewAmsterdam Pharma. We are hopeful that NewAmsterdam Pharma is part of that solution with obicetrapib.” Overall, this leads to more cholesterol being removed from the body. What approaches is NewAmsterdam Pharma focusing on in relation to patient enrolment?

Pharma 97

Pharma Patients Pharmaceutical Leads 97

Pharmaceutical Technology

MAY 15, 2023

Patent volumes related to oxazole derivatives-based cancer drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F. Hoffmann-La Roche is the leading patent filer of oxazole derivatives-based cancer drug compositions.

Leads 52

Leads Biopharma Pharmaceutical Pharma 52

Pharmaceutical Technology

MAY 15, 2023

In terms of application diversity, Ascentawits Pharmaceuticals is the top company, followed by OBI Pharma and Mabwell Shanghai Bioscience. ‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 52

Leads Biopharma Pharmaceutical Pharma 52

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Periodontitis drugs is a notable innovation area in the pharmaceutical industry Periodontal diseases, which may lead to the damage of teeth or bone, are caused by infections and inflammation of the gums and bone that surround and support the teeth.

Leads 52

Leads Pharmaceutical Physicians Food 52

Pharmaceutical Technology

MAY 8, 2023

Patent volumes related to monoclonal antibody conjugates for cancer treatment Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F. Hoffmann-La Roche is the leading patent filer in monoclonal antibody conjugates for cancer treatment.

Leads 52

Leads Pharmaceutical Biopharma Pharma 52

Pharmaceutical Technology

MAY 15, 2023

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. Akamis Bio, formerly PsiOxus Therapeutics, develops and discovers therapies for the treatment of cancer and other related diseases.

Leads 52

Leads Pharmaceutical Pharma 52

Pharmaceutical Technology

MAY 24, 2023

Patent volumes related to tetrapeptide derivatives space Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Amgen 317 Unlock company profile Bristol-Myers Squibb 281 Unlock company profile F.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Pharmacology 52

Pharmaceutical Technology

MAY 8, 2023

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’. The company develops drugs for the management of pain.

Pharmaceutical 52

Pharmaceutical Leads Side effects Medicine 52

European Pharmaceutical Review

OCTOBER 2, 2023

This leads to their activation and the release of inflammatory signalling molecules. In 2010, several companies were working on developing the method. The organisation stated that in their research, Karikó and Weissman noticed that dendritic cells recognise in vitro transcribed mRNA as a foreign substance.

Medicine 111

Medicine Pharmaceutical Pharma Leads 111

Pharmaceutical Technology

MAY 24, 2023

Patent volumes related to recombinant viral vector-based medicinal preparations Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies C.

Medicine 52

Medicine Pharmaceutical Leads Prescription 52

pharmaphorum

JULY 27, 2022

The paper, by a team from Imperial College London, concluded that the FDA gave the go ahead to 95% of the 89 products approved between 2010 and 2019 before EMA, with the Europeans trailing the Americans by a median of 241 days. R&D success. To read the full report, click here. . About the author.

Government 98

Government Recruitment Medicine Patients 98

European Pharmaceutical Review

SEPTEMBER 14, 2023

For both small biotechs and large pharma, economic uncertainty is rising, intensifying decision-making risks associated with early drug discovery efforts, clinical trials, quality and manufacturing process execution, and navigating the approval process. Risks you cannot control largely come down to science.

Manufacturing 98

Manufacturing Management Engineering Pharmaceutical 98

PM360

NOVEMBER 29, 2022

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. At the same time, MSLs are being asked to help inform brand strategy with their learnings from talking to leading healthcare professionals. If you apply the right AI engines, you will get increasingly better insights.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

pharmaphorum

AUGUST 5, 2022

Such inorganic growth is no longer viable, argues Pervaise Khan, Accenture’s UK Life Sciences Lead. Through our recent report, Scientific innovations for more sustainable growth , we analysed over 300 M&A deals made by the world’s top 30 biopharma companies between 2010–2021. 1] Accenture Research, leveraging evaluate pharma data.

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

pharmaphorum

NOVEMBER 15, 2022

Describing the current macro environment, Levin remarked that 2022 feels similar to the long grind witnessed in 2010, with budgets stretched in response to financial uncertainty. Back in the main hall, we headed over to the Start-Up Stage for a panel discussion hosted by pharma giant Eli Lilly. For Müllenbeck, this is an opportunity.

Healthcare 96

Healthcare Healthcare Management Marketing 96

Clarivate

NOVEMBER 8, 2022

Beyond these household names there is an entire world of innovator companies – plucky startups and well-resourced large pharmas alike – looking to leverage this emerging technology to treat and even cure a wide variety of diseases. . DTx Pharma Inc., Cargene Biopharma Inc., a San Diego (U.S.)-based

Pharma 52

Pharma Biopharma Marketing FDA 52

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. By 2025, pharma’s investment in AI is expected to reach $3 billion. About Debiopharm Innovation Fund.

Medicine 105

Medicine Patients Healthcare Healthcare 105

Pharma Marketing Network

OCTOBER 11, 2021

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. Amy Turnquist, PMN EAB Member, and Principal at North Highland lead this insightful panel.

Healthcare 59

Healthcare Healthcare Marketing Insurance 59

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. A pay-for-outcomes contract between a payer and a pharma company needs to be adjudicated.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Pharma Marketing Network

OCTOBER 11, 2021

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. Amy Turnquist, PMN EAB Member, and Principal at North Highland lead this insightful panel.

Healthcare 52

Healthcare Healthcare Marketing Insurance 52

Pharmaceutical Technology

MARCH 24, 2023

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. The primary reasons for delayed market entry in the US revolve around patent disputes.

Competition 59

Competition Marketing FDA Physicians 59

Pharmaceutical Technology

OCTOBER 5, 2008

But the recent acquisition by Japanese pharmaceutical provider Shionogi of US-based rival Sciele Pharma, worth $1,276m, is just the latest in a spree of big and bold outbound deals. Like in many other sectors, China and India are the ones labelled as those which will lead the expansion. % in India.

Government 40

Government Marketing Pharmaceutical Physicians 40

PM360

OCTOBER 24, 2022

Those qualities and his passion for advertising would help him found and lead not one but two award-winning healthcare agencies in Wishbone (1998) and Calcium (2012), and become in the eyes of Greg Lewis, Managing Partner, President of Calcium, “an advertising hero…a legend.”. It’s part of why we say Calcium is all about nourishment.

Marketing 40

Marketing Education Management Leads 40

Evolve Your Success

OCTOBER 18, 2022

I’m sure that you are in the biotech pharma world making good money and your ego was like, “Stay here and make money,” but your intuition was like, “No. It encompasses biotech, pharma, dental and diagnostic. You might be in pharma, war-based surgical role, diagnostic testing, genetic testing or whatever your role is.

Marketing 52

Marketing Sales Medical sales Medical 52

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. The Pharma Spin. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Cadensee

JULY 14, 2021

Our first fund, that was back in 2010, we had about five strategic partners that invested; Johnson & Johnson, Medtronic, Abbott, and Volcano at the time, that basically wanted more exposure to Israel. And we do have an office in the Bay Area where my partner Peter Fitzgerald, leads the effort.

Marketing 52

Marketing Doctors Medical Management 52

Healthcare Success

NOVEMBER 25, 2024

The systems that adapt and integrate the fastest will be the ones that lead the future of care." John Marchica So when I got out of school the 1st time I cut my teeth at Abbott, so I was a Pharma guy, because the division that I was in later became AV when they kind of split the company apart. John Marchica Sure. Stewart Gandolf Yeah.

Healthcare 62

Healthcare Healthcare Doctors Physicians 62

Pharmaceutical Technology

JUNE 8, 2023

Household names are leading the way. Of the world’s 20 largest pharmaceutical companies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. It is a trend that shows no signs of slowing down. Source: GlobalData.

Pharmaceutical 52

Pharmaceutical Media Transportation Pharma 52

Pharmaceutical Technology

MARCH 15, 2023

According to GlobalData’s Pharma Intelligence Center Deals Database, figure 1 shows the parent holding company SVB Financial Group and its subsidiaries were involved in more than $1.4bn in total venture financing raised from 2010 to 2022 for drug development. in deposits.

Medicine 59

Medicine Marketing Pharma Government 59